OR WAIT null SECS
December 09, 2021
Sanofi’s acquisition of Origimm Biotechnology will add to its pipeline of vaccine candidates for treating acne.
November 29, 2021
Samsung Biologics, GreenLight Biosciences, and Environmental Impact Acquisition Corp. have partnered to advance GreenLight’s mRNA COVID-19 vaccine candidate.
The companies are testing their existing vaccines against the new variant of concern and are pursuing variant-specific versions.
The Comirnaty vaccine received a positive opinion from the EMA’s CHMP for children five to under 12 years of age.
November 19, 2021
Novavax has announced that EMA has started its review of a conditional marketing authorization application for its COVID-19 vaccine, NVX-CoV2373.
November 10, 2021
The agency is evaluating Moderna’s application for use of Spikevax in children aged 6 to 11.
November 03, 2021
Alternative drug delivery approaches are promising, but due to their complexity, they need to be sufficiently justified.
October 29, 2021
Novavax has filed its COVID-19 vaccine for authorization in the UK and Australia.
October 22, 2021
EMA's CHMP has approved two new manufacturing sites and a ready-to-use formulation of Comirnaty.
EMA has started its evaluation of further expanded use of Comirnaty in children aged between five years and 11 years old.